Nuclear cardiology will remain the “gatekeeper” over CT angiography
- Cite this article as:
- Hachamovitch, R. & Di Carli, M.F. J Nucl Cardiol (2007) 14: 634. doi:10.1016/j.nuclcard.2007.06.118
- 86 Downloads
Although CTA is a promising new modality, from an evidence-based point of view there is no data to support its use in a testing strategy, its accuracy is unlikely to be sufficiently similar to invasive catheterization to be considered its equivalent, and most importantly, it appears that stress perfusion data will be needed to select which patients may most benefit from revascularization and, hence, referral to the catheterization laboratory.